The long-duration response to levodopa: Phenomenology, potential mechanisms and clinical implications

Elise Anderson, John Nutt

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The antiparkinsonian response to levodopa is characterized by an immediate motor improvement lasting hours and a more sustained response lasting days. These two responses have been referred to as the short-duration response (SDR) and the long-duration response (LDR). The LDR represents a substantial component of the clinical effect of levodopa and has been clinically recognized for several decades, but it remains poorly understood. This review will focus on the LDR phenomenology and theories about its origin, with the goal of promoting inquiry into this important but as yet poorly understood aspect of levodopa therapy for PD.

Original languageEnglish (US)
Pages (from-to)587-592
Number of pages6
JournalParkinsonism and Related Disorders
Volume17
Issue number8
DOIs
StatePublished - Sep 2011

Fingerprint

Levodopa
Antiparkinson Agents
Therapeutics

Keywords

  • LDR
  • Levodopa
  • Long duration response
  • Parkinson's disease

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Clinical Neurology
  • Neurology

Cite this

The long-duration response to levodopa : Phenomenology, potential mechanisms and clinical implications. / Anderson, Elise; Nutt, John.

In: Parkinsonism and Related Disorders, Vol. 17, No. 8, 09.2011, p. 587-592.

Research output: Contribution to journalArticle

@article{ee2cd747ac0647d1ac538ad2aba014ea,
title = "The long-duration response to levodopa: Phenomenology, potential mechanisms and clinical implications",
abstract = "The antiparkinsonian response to levodopa is characterized by an immediate motor improvement lasting hours and a more sustained response lasting days. These two responses have been referred to as the short-duration response (SDR) and the long-duration response (LDR). The LDR represents a substantial component of the clinical effect of levodopa and has been clinically recognized for several decades, but it remains poorly understood. This review will focus on the LDR phenomenology and theories about its origin, with the goal of promoting inquiry into this important but as yet poorly understood aspect of levodopa therapy for PD.",
keywords = "LDR, Levodopa, Long duration response, Parkinson's disease",
author = "Elise Anderson and John Nutt",
year = "2011",
month = "9",
doi = "10.1016/j.parkreldis.2011.03.014",
language = "English (US)",
volume = "17",
pages = "587--592",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "8",

}

TY - JOUR

T1 - The long-duration response to levodopa

T2 - Phenomenology, potential mechanisms and clinical implications

AU - Anderson, Elise

AU - Nutt, John

PY - 2011/9

Y1 - 2011/9

N2 - The antiparkinsonian response to levodopa is characterized by an immediate motor improvement lasting hours and a more sustained response lasting days. These two responses have been referred to as the short-duration response (SDR) and the long-duration response (LDR). The LDR represents a substantial component of the clinical effect of levodopa and has been clinically recognized for several decades, but it remains poorly understood. This review will focus on the LDR phenomenology and theories about its origin, with the goal of promoting inquiry into this important but as yet poorly understood aspect of levodopa therapy for PD.

AB - The antiparkinsonian response to levodopa is characterized by an immediate motor improvement lasting hours and a more sustained response lasting days. These two responses have been referred to as the short-duration response (SDR) and the long-duration response (LDR). The LDR represents a substantial component of the clinical effect of levodopa and has been clinically recognized for several decades, but it remains poorly understood. This review will focus on the LDR phenomenology and theories about its origin, with the goal of promoting inquiry into this important but as yet poorly understood aspect of levodopa therapy for PD.

KW - LDR

KW - Levodopa

KW - Long duration response

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=80052351842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052351842&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2011.03.014

DO - 10.1016/j.parkreldis.2011.03.014

M3 - Article

C2 - 21530356

AN - SCOPUS:80052351842

VL - 17

SP - 587

EP - 592

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 8

ER -